38.89MMarket Cap-1898P/E (TTM)
1.130High0.965Low230.21KVolume0.965Open0.969Pre Close243.45KTurnover4.32%Turnover RatioLossP/E (Static)34.73MShares1.96052wk High-1.91P/B5.97MFloat Cap0.75052wk Low--Dividend TTM5.33MShs Float22.155Historical High--Div YieldTTM17.04%Amplitude0.750Historical Low1.057Avg Price1Lot Size
MiNK Therapeutics Stock Forum
MiNK Therapeutics, Inc. (NASDAQ: INKT), a company in the biopharmaceutical sector, has announced an essential milestone in its quest to revolutionize cancer treatment. With a focus on developing allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies for cancer and other immune-mediated diseases, MiNK has...
MiNK Therapeutics Shares Are Trading Higher After the Company Announced Plans to Sell Securities in a Private Placement Financing for $5.8 Million. The Financing Is Earmarked for Accelerating Its MiNK-215 Clinical Trials
NEWS
MiNK Therapeutics Announces $5.8 Million Private Placement and Appointment of Board Observer
CEO bought a lot
Gene therapies..hot cake for now and duti
ER May 11
No comment yet